MedPath

Florzolotau F-18

Generic Name
Florzolotau F-18
Drug Type
Small Molecule
Chemical Formula
C20H20FN3O2S
CAS Number
1565797-57-0
Unique Ingredient Identifier
51M993JIQ4

Overview

PMPBB3 F-18 is under investigation in clinical trial NCT04305210 (Alzheimer's Disease: Clinical Investigation and Neuroimage Studies Including 18F-PM-PBB3 and 18f-florbetapir (AV-45) PET Examination).

Background

PMPBB3 F-18 is under investigation in clinical trial NCT04305210 (Alzheimer's Disease: Clinical Investigation and Neuroimage Studies Including 18F-PM-PBB3 and 18f-florbetapir (AV-45) PET Examination).

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Phase 3
Recruiting
Posted: 2022/09/16
Sponsor:
APRINOIA Therapeutic...
Phase 1
Posted: 2020/01/30
Sponsor:
Chang Gung Memorial ...
Phase 1
Posted: 2020/01/27
Sponsor:
Chang Gung Memorial ...
Phase 2
Active, not recruiting
Posted: 2019/10/28
Sponsor:
APRINOIA Therapeutic...

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath